The Dextroverse

Article Tools
Wiki Links
Wiki (List)

Default Zenvia (dextromethorphan/quinidine)
Zenvia is a medication by Avanir Pharmaceuticals currently in development for the treatment of pseudobulbar affect. This neurological disorder is characterized by involuntary crying, uncontrollable episodes of crying and/or laughing, or other emotional displays. Zenvia contains dextromethorphan and quinidine in both 30/10 mg and 20/10 mg formulations. Quinidine is a CYP2D6 inhibitor which prevents the metabolization of DXM to DXO. This results in increased bioavailability of dextromethorphan. Zenvia will potentially be approved by the FDA as a prescription drug in the fourth calendar quarter of 2010.[1]

  1. ^ "AVANIR Pharmaceuticals Submits Complete Response to FDA Approvable Letter for Zenvia in PBA." EON 30 Apr. 2010. accessed 22 Jul 2010.

Created by viscosity, 07-22-2010 at 05:32 PM
Last edited by viscosity, 07-22-2010 at 05:33 PM
0 Comments, 270 Views

Posting Rules
You may not create new articles
You may not edit articles
You may not protect articles

You may not post comments
You may not post attachments
You may not edit your comments

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Powered by vBulletin® Version 3.8.4
Copyright ©2000 - 2010, Jelsoft Enterprises Ltd.
vBulletin Skin developed by:

"Wiki" powered by VaultWiki v2.5.0.
Copyright © 2008 - 2010, Cracked Egg Studios.